Cytomed Therapeutics Limited Stock Price on November 17, 2023
| GDTC Stock | 2.25 0.11 4.66% |
If you're considering investing in CytoMed Stock, it is important to understand the factors that can impact its price. As of today, the current price of CytoMed Therapeutics stands at 2.25, as last reported on the 28th of March, with the highest price reaching 2.54 and the lowest price hitting 2.25 during the day. CytoMed Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0381, which signifies that the company had a -0.0381 % return per unit of risk over the last 3 months. CytoMed Therapeutics Limited exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CytoMed Therapeutics' Risk Adjusted Performance of 0.0342, mean deviation of 4.05, and Downside Deviation of 7.5 to double-check the risk estimate we provide.
At present, CytoMed Therapeutics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 21.7 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 8.1 M. . At present, CytoMed Therapeutics' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price Sales Ratio is expected to grow to 316.54, whereas Price Earnings Ratio is forecasted to decline to (15.72). CytoMed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
CytoMed |
Sharpe Ratio = -0.0381
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GDTC |
Estimated Market Risk
| 6.14 actual daily | 54 54% of assets are less volatile |
Expected Return
| -0.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CytoMed Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CytoMed Therapeutics by adding CytoMed Therapeutics to a well-diversified portfolio.
Price Book 3.5886 | Enterprise Value Ebitda (4.45) | Price Sales 60.8326 | Shares Float 3.5 M | Wall Street Target Price 5 |
CytoMed Therapeutics Valuation on November 17, 2023
It is possible to determine the worth of CytoMed Therapeutics on a given historical date. On November 17, 2023 CytoMed was worth 3.8 at the beginning of the trading date compared to the closed value of 3.72. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CytoMed Therapeutics stock. Still, in general, we apply an absolute valuation method to find CytoMed Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of CytoMed Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CytoMed Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.87 | 4.07 | 3.87 | 4.07 | 600.00 | |
11/17/2023 | 3.80 | 3.80 | 3.72 | 3.72 | 3,500 |
| 3.72 | 3.75 | 3.65 | 3.70 | 1,500 |
| Backtest CytoMed Therapeutics | | | CytoMed Therapeutics History | | | CytoMed Therapeutics Valuation | Previous | Next |
CytoMed Therapeutics Trading Date Momentum on November 17, 2023
| On November 20 2023 CytoMed Therapeutics Limited was traded for 3.70 at the closing time. The top price for the day was 3.75 and the lowest listed price was 3.65 . The trading volume for the day was 1.5 K. The trading history from November 20, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.54% . The overall trading delta against the current closing price is 2.69% . |
CytoMed Therapeutics Fundamentals Correlations and Trends
By evaluating CytoMed Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among CytoMed Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CytoMed financial account trend analysis is a perfect complement when working with valuation or volatility modules.About CytoMed Therapeutics Stock history
CytoMed Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CytoMed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CytoMed Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CytoMed Therapeutics stock prices may prove useful in developing a viable investing in CytoMed Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 12.2 M | 8.1 M | |
| Net Loss | -2.8 M | -3 M |
CytoMed Therapeutics Stock Technical Analysis
CytoMed Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
CytoMed Therapeutics Period Price Range
Low | March 28, 2025
| High |
0.00 | 0.00 |
CytoMed Therapeutics Limited cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
CytoMed Therapeutics March 28, 2025 Market Strength
Market strength indicators help investors to evaluate how CytoMed Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CytoMed Therapeutics shares will generate the highest return on investment. By undertsting and applying CytoMed Therapeutics stock market strength indicators, traders can identify CytoMed Therapeutics Limited entry and exit signals to maximize returns
CytoMed Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CytoMed Therapeutics' price direction in advance. Along with the technical and fundamental analysis of CytoMed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CytoMed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0342 | |||
| Jensen Alpha | 0.2098 | |||
| Total Risk Alpha | 0.3728 | |||
| Sortino Ratio | 0.0275 | |||
| Treynor Ratio | 0.1595 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for CytoMed Stock analysis
When running CytoMed Therapeutics' price analysis, check to measure CytoMed Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytoMed Therapeutics is operating at the current time. Most of CytoMed Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytoMed Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytoMed Therapeutics' price. Additionally, you may evaluate how the addition of CytoMed Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |